Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,783 | 60,965 | 71,847 | 75,372 | 76,416 |
| Marketable Securities | 7,035 | 7,178 | 15,554 | 23,486 | 23,649 |
| Receivables | 14,029 | 5,620 | 5,380 | 21,317 | 60,129 |
| Other current assets | 1 | 0 | 0 | 1 | -1 |
| TOTAL | $52,848 | $73,763 | $92,781 | $120,176 | $160,193 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5,625 | N/A | N/A | N/A |
| Investments And Advances | 11,829 | 11,795 | 11,125 | 11,146 | 10,602 |
| Other Non-Current Assets | 1,355 | 14,318 | 10,716 | 25,636 | 21,714 |
| TOTAL | $13,184 | $31,738 | $21,841 | $36,782 | $32,316 |
| Total Assets | $70,960 | $105,502 | $120,177 | $163,147 | $199,352 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,959 | 10,142 | 9,424 | 9,616 | 9,671 |
| Accounts payable and accrued liabilities | 17,019 | 13,669 | 17,321 | 17,094 | 18,419 |
| Other current liabilities | 14,488 | 8,955 | 8,945 | 14,454 | 14,809 |
| TOTAL | $41,465 | $33,404 | $35,690 | $41,163 | $42,899 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,581 | 20,541 | 24,116 | 28,618 | 33,505 |
| Deferred Revenues | N/A | 639 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 38,471 | 42,734 | 47,755 | 48,100 | 52,030 |
| TOTAL | $54,052 | $66,258 | $74,928 | $90,975 | $100,280 |
| Total Liabilities | $95,516 | $99,663 | $110,618 | $132,138 | $143,180 |
| Shareholders' Equity | |||||
| Common Shares | 5,303 | 5,233 | 4,536 | 4,360 | 4,377 |
| Retained earnings | -492,772 | -462,830 | -418,085 | -389,468 | -364,619 |
| Other shareholders' equity | 1,264 | 1,355 | 30 | 382 | 535 |
| TOTAL | $-24,556 | $5,840 | $9,559 | $31,010 | $56,172 |
| Total Liabilities And Equity | $70,960 | $105,502 | $120,177 | $163,148 | $199,352 |